FILTER

FILTERED INTERVIEW RESULTS

Luca Candioli

OWNER & GENERAL MANAGER, CANDIOLI PHARMA
Italian animal health company Candioli explains how it intends to double in size during the next five years.

Paolo Tubertini

CEO, OLON
Olon has expanded from production of APIs and intermediates to include CDMO and Biotech operations in Italy and beyond.

Manni Kantipudi & Ramesh Subramanian

CEO & CCO, ARAGEN LIFE SCIENCES
Aragen Life Sciences continues its rapid expansion and celebrates its best year ever.

Salvatore Butti

PRESIDENT, ASSOSALUTE - FEDERCHIMICA
Assosalute represents non-prescription medical products in Italy and explains how easing regulations could be of huge benefit to Italians and the healthcare system.

Dr. Siva Samy

CEO & CHIEF PRODUCT STRATEGIST, VALGENESIS
ValGenesis explains how it streamlines the validation process to allow real-time access to validation documents and data enabling various stakeholders to achieve compliance efficiently.

Michael Kauffman

CEO, KARYOPHARM THERAPEUTICS
GBR speaks to Karyopharm Therapeutics about the commercialization of XPOVIO.

Paolo Russolo

PRESIDENT, ASCHIMFARMA – FEDERCHIMICA
Aschimfarma explains to GBR how Italian producers of APIs are well positioned to strengthen the European drug supply chain.

Eric Ostertag M.D., Ph.D.

CEO, POSEIDA THERAPEUTICS
Poseida Therapeutics explains how progress in gene therapy offers the possibility to provide single treatment cures for cancer and other genetic diseases.

Amit Munshi

PRESIDENT & CEO, ARENA PHARMACEUTICALS
Arena Pharmaceuticals speaks to GBR about building its pipeline and infrastructure.

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

Africa Energy 2024 - Pre-release

The pre-release edition of Africa Energy 2024 comprises analysis based on over 80 interviews with ministers and leading executives from IOCs, NOCs, independents, associations, investors and service providers, to provide an in-depth and holistic view of sub-Saharan Africa’s ever-evolving energy sector.

PARTNER EVENTS